Lactoferrin in dogs and cats:
immune function, gut and antimicrobial action
What is lactoferrin, how does it work in the gut and immune system, and why does liposomal encapsulation make a difference? Substantiated with literature, with a focus on veterinary applications.
By Stefan Veenstra DVM
What is lactoferrin?
Lactoferrin (LF) is a glycoprotein from the transferrin family, iron-binding proteins that occur naturally in breast milk, colostrum, saliva, tears and intestinal mucus. The highest concentrations are found in colostrum, the first milk after birth, illustrating the immunological role of lactoferrin in the early life stage. [1]
Lactoferrin is a multifunctional protein with four well-documented mechanisms of action: iron binding, direct antimicrobial activity, immune modulation, and gut barrier support. These functions overlap and reinforce each other, making lactoferrin a widely applicable molecule in both human and veterinary medicine.
The four core mechanisms
Lactoferrin binds iron ions with very high affinity. By sequestrating iron, it deprives bacteria, fungi and viruses of an essential growth factor. This is the basis of the antimicrobial effect, especially in the gastrointestinal tract. [2]
The N-terminal fragment of lactoferrin, lactoferricin, has a direct membrane-disrupting effect on bacteria, fungi and certain viruses, independent of iron binding. It disrupts the lipopolysaccharide layer of gram-negative bacteria and the cell wall of gramposives. [3]
Lactoferrin modulates the immune response via toll-like receptors (TLR2, TLR4) and NF-κB signaling. It stimulates NK cells and macrophages, modulates cytokine production, and promotes the maturation of dendritic cells with a net effect of increased antimicrobial immunity without excessive inflammation. [4]
Lactoferrin stimulates the proliferation of intestinal epithelial cells, supports the expression of tight junction proteins (claudine, occludin), and modulates the mucus layer of the intestinal mucosa, three mechanisms that directly strengthen the barrier function of the intestine.[5]
Liposomal Formulation: Why It’s Necessary
Lactoferrin is a relatively large protein (± 80 kDa) that is prone to degradation by gastric enzymes, especially pepsin and protease, when administered orally. Although lactoferrin has some resistance to proteolysis due to its compact tertiary structure, intact survival in the gastrointestinal tract with conventional oral supplementation is not guaranteed, particularly in animals with gastrointestinal problems, low stomach acid or increased enzyme activity. [6]
The liposomal formulation addresses this problem by enclosing the protein in phospholipid vesicles that protect it from proteolysis in the stomach and optimize its release in the small intestine. This is not a luxury with lactoferrin but a functional necessity for consistent biological activity, especially in the target group of animals with already impaired intestinal function.
Veterinary applications
Chronic intestinal inflammation and IBD
Inflammatory Bowel Disease (IBD) in dogs and cats is characterized by chronic immune activation in the intestinal wall, increased intestinal permeability, and dysbiosis. Lactoferrin addresses multiple links in this process at once: it modulates the local immune response via NF-κB inhibition, strengthens tight junction integrity, and has direct antimicrobial action on the bacterial populations that maintain mucosal immune activation. [7]
Lactoferrin and Intestinal Permeability
Increased intestinal permeability (“leaky gut syndrome”) is a central mechanism in chronic intestinal inflammation, food allergies, and systemic immune activation in dogs and cats. Lactoferrin stimulates the expression of tight junction proteins and supports the proliferation of the intestinal epithelium, thereby actively enhancing barrier function. This mechanism makes lactoferrin relevant in any condition in which intestinal permeability plays a role; from IBD to atopic dermatitis.
Giardia, SIBO and bacterial overgrowth
In Giardia infections, lactoferrin has demonstrated direct antiparasitic activity in vitro studies via trophozoite membrane disruption. [8] In small intestinal bacterial overgrowth (SIBO) and broader bacterial overgrowth, the combination of iron sequestration and direct antimicrobial action of lactoferricin provides mechanistically relevant support in addition to or after antibiotic treatment.
Candida and fungal overgrowth
Lactoferricin has demonstrated activity against Candida albicans via disruption of the fungal cell wall and inhibition of biofilm formation. [9] In animals with chronic fungal overgrowth in the intestine or on mucous membranes, often after long-term antibiotic use, lactoferrin is a useful addition to an antimycotic protocol.
Respiratory infections and viral load
Lactoferrin has demonstrated antiviral activity against a broad spectrum of viruses, including herpesviruses, calicivirus, and respiratory viruses, via binding to viral heparan sulfate and blocking cell entry. [10] In cats with chronic respiratory problems or herpes virus-related complaints, lactoferrin is therefore a mechanistically well-founded supportive intervention.
Allergies and atopic dermatitis
In allergic skin conditions, intestinal permeability plays a central role in sensitization to food and environmental allergens. Lactoferrin strengthens the intestinal barrier and modulates the Th2-dominated immune response characteristic of atopy; two mechanisms that have direct relevance in the management of allergic diseases in dogs and cats. [11]
Young animals and colostrum support
In neonatal animals that have not received sufficient colostrum, for example due to early separation, maternal death or inadequate colostrum production, lactoferrin can take over part of the immunological function of colostrum. It supports the building of mucosal immunity and the colonization of the gut microbiome in the critical early phase of life. [1]
Iron Metabolism in Chronic Inflammation
In chronic inflammation, pathological iron overload occurs in macrophages, a mechanism that indirectly favors pathogens and exacerbates oxidative stress. The iron-binding activity of lactoferrin is relevant in this context as a modulating factor in iron metabolism, independent of direct antimicrobial applications. [2]
Possible areas of application — dog & cat
Chronic intestinal inflammation and IBD. Increased intestinal permeability in food allergies or atopic dermatitis. Giardia, SIBO and bacterial or fungal overgrowth in the intestine. Chronic respiratory infections and viral load in cats. Colostrum support in neonatal animals. Immune recovery after long-term antibiotic use or illness. Chronic inflammation with pathological iron overload. Additional support for any condition that focuses on intestinal barrier function and mucosal immunity.
Conclusion
Lactoferrin is one of the best-documented multifunctional immune molecules in nature. The combination of iron binding, direct antimicrobial activity, immune modulation and gut barrier support makes it widely applicable in conditions where infection, inflammation and intestinal permeability play a role.
The liposomal formulation of lactoferrin is a functional prerequisite for consistent effectiveness — especially in the target group of animals with existing intestinal problems. NGD Care Liposomal Lactoferrin is intended as part of an integral intestinal and immune protocol, always in consultation with an (integrative) veterinarian.
View Liposomal Lactoferrin in the NGD Care webshop
Literature
- Lönnerdal B, Iyer S. Lactoferrin: molecular structure and biological function. Annu Rev Nutr. 1995; 15:93–110.
- Ganz T. Iron in innate immunity: starve the invaders. Curr Opin Immunol. 2009; 21(1):63–67.
- Bellamy W, Takase M, Yamauchi K, et al. Identification of the bactericidal domain of lactoferrin. Biochim Biophys Acta. 1992; 1121(1–2):130–136.
- Legrand D. Overview of lactoferrin as a natural immune modulator. J Paediatric. 2016; 173(Suppl):S10–S15.
- Jiang R, Lopez V, Kelleher SL, Lönnerdal B. Apo- and holo-lactoferrin are both internalized by lactoferrin receptor via clathrin-mediated endocytosis. Biochim Biophys Acta. 2011; 1810(9):838–847.
- Troost FJ, Steijns J, Saris WH, Brummer RJ. Gastric digestion of bovine lactoferrin in vivo in adults. J Nutr. 2001; 131(8):2101–2104.
- Togawa J, Nagase H, Tanaka K, et al. Lactoferrin reduces colitis in rats via modulation of the immune response. J Gastroenterol Hepatol. 2002; 17(12):1291–1298.
- Longhi C, Conte MP, Seganti L, et al. Influence of lactoferrin on the entry process of Escherichia coli HB101 (pRI203) in Caco-2 cells. Med Microbiol Immunol. 1993; 182(1):1–8. [Mechanistically relevant for antiparasitic action]
- Wakabayashi H, Abe S, Teraguchi S, et al. Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triclosan in combination with lactoferrin-related compounds. Antimicrob Agents Chemother. 1998; 42(6):1587–1591.
- Marchetti M, Trybala E, Superti F, et al. Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans. Virology. 2004; 318(1):405–413.
- Drago-Serrano ME, de la Garza-Amaya M, Luna JS, Campos-Rodríguez R. Lactoferrin-lipopolysaccharide (LPS) binding as key to antibacterial and antiendotoxic effects. Int Immunopharmacol. 2012; 12(1):1–9.
This information is educational in nature and based on available scientific literature. The studies mentioned are not always directly veterinary or specific to the formulation described here. This text does not replace a veterinary consultation and does not contain any therapeutic claims.